Neuro-Oncology

Published by: Oxford University Press  

People

  1. Brennan
    Brennan
  2. Avila
    Avila
  3. Tabar
    Tabar
  4. Reiner
    Reiner
  5. Kaley
    Kaley
  6. Moss
    Moss
  7. Panageas
    Panageas
  8. Young
    Young
  9. Mellinghoff
    Mellinghoff
  10. Diamond
    Diamond

Groups

  1. Critical Care Center Leadership (51)
  2. Critical Care Center (51)
  3. GSK Faculty (14)
  4. Tow Center for Developmental Oncology (TCDO) (13)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (11)
  6. Sloan Kettering Institute Postdocs (9)
  7. Epidemiology and Biostatistics (8)
  8. Multidisciplinary Brain Metastasis Program (8)
  9. Radiology, Department of (8)
  10. Human Oncology and Pathogenesis Program (7)
Search Within
  1. "Critical Care Center "
Formats
  1. Meeting Abstract (40)
  2. Journal Article (8)
  3. Review (2)
  4. Guidelines (1)
Groups
  1. Critical Care Center (51)
  2. Critical Care Center Leadership (51)
  3. GSK Faculty (14)
  4. Tow Center for Developmental Oncology (TCDO) (13)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (11)
  6. Sloan Kettering Institute Postdocs (9)

More Groups

People
  1. Cameron Brennan (37)
  2. Edward Avila (14)
  3. Viviane Tabar (9)
  4. Anne Reiner (7)
  5. Jason Huse (6)
  6. Katherine Panageas (6)

More People

Years
  1. 2025 (2)
  2. 2024 (4)
  3. 2023 (2)
  4. 2022 (4)
  5. 2021 (1)
  6. 2020 (6)

More Years

Publishers
  1. Oxford University Press (51)

Results (51)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Response Assessment in Neuro-Oncology (RANO) 2009-2025: Broad scope and implementation—A progress report
    Review

    van den Bent, M. J.; Vogelbaum, M. A.; Cloughesy, T.; Galldiks, N.; Albert, N. L.; Tonn, J. C.; Avila, E.; Fangusaro, J.; Mirsky, D.; Sahgal, A.; more...
    Neuro-Oncology (2025)

    Fulltext@MSK | Save
  • RANO seizure working group-Tumor-Related Epilepsy Assessment Tool (RANO-TREAT) to assess seizure control for glioma treatment trials and clinical practice
    Journal Article

    Avila, E. K.; Reiner, A. S.; Armstrong, T. S.; Aaroe, A. E.; Cunningham, E. M.; Brown, J. G.; Bruno, F.; Diarte, J.; Haggiagi, A.; Harrison, R. A.; more...
    Neuro-Oncology (2025)

    Fulltext@MSK | Save
  • Prospective germline sequencing of patients with gliomas, glioneuronal or neuronal tumors
    Meeting Abstract

    Lin, A.; Nandakumar, S.; Mehine, M.; Kemel, Y.; Mandelker, D.; Karajannis, M.; Sait, S. F.; Gavrilovic, I.; Pentsova, E.; Schaff, L.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Long term follow-up of resection plus cesium-131 brachytherapy for previously irradiated recurrent brain metastases
    Meeting Abstract

    Yacoub, I.; Young, R. J.; Reiner, A. S.; Gantini-Larsen, A.; Yamada, Y.; Pike, L. R. G.; Krebs, S.; Damato, A.; Aramburu-Nunez, D.; Yu, K. K. H.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Early safety data from a randomized, multicenter, double-blind, phase 2b study of IGV-001, an autologous cell immunotherapy, versus placebo, in newly diagnosed glioblastoma
    Meeting Abstract

    Hanft, S.; Elder, B.; Giglio, P.; Wu, S. H.; Farrell, C.; Alnahhas, I.; Lee, I. Y.; Walbert, T.; Boockvar, J.; Vojnic, M.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management
    Review

    Avila, E. K.; Tobochnik, S.; Inati, S. K.; Koekkoek, J. A. F.; McKhann, G. M.; Riviello, J. J.; Rudà, R.; Schiff, D.; Tatum, W. O.; Templer, J. W.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • A randomized, multicenter, double blind, phase 2B study of Igv-001, an autologous cell immunotherapy with antisense oligo IMV-001 targeting IGF-1R, vs placebo, in newly diagnosed glioblastoma patients
    Meeting Abstract

    Lee, I.; Judy, K.; Schulder, M.; Hanft, S.; Evans, L.; Wu, J.; Aulakh, S.; Wong, E.; Agarwal, V.; Ramakrishna, R.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Evaluation of immunotherapy effects in cancer patients on epileptiform activity
    Meeting Abstract

    Wong, K.; Thakur, A.; Zuidema, E.; Avila, E.; Chen, X.; Lai, G.; Mao, D.
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Utility of the Seizure Control Composite Index (RANO-SCCI) in evaluating seizures in CNS tumor patients
    Meeting Abstract

    Miller, H.; Christ, A.; Grajkowska, E.; Acquaye, A.; Adegbesan, K.; Boris, L.; Burton, E.; Chambers, C.; Choi, A.; Evans, K.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save
  • Improving acute stroke response at a comprehensive cancer center: A multidisciplinary hospital-based quality improvement project
    Meeting Abstract

    Quashie, W.; Avila, E.; Barzola, M.; Buchholz, T.; Majeed, J.; Santa Maria, N.; Schaff, L.
    Neuro-Oncology (2022)

    Fulltext@MSK | Save

    • Neuro-Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-oncology 15235866 Unknown
    Neuro-Oncology 15228517 The Author(s) 2024
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 The Author(s)
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1522-8517 Carden Jennings Publ Co Ltd
    Neuro-Oncology 1522-8517 Duke University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 Unknown
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 The Author(s) 2023
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-oncology 15235866 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1522-8517 Duke University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15235866 Elsevier B.V.
    Neuro-Oncology 1522-8517 Society for Neuro Oncology